Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Actavis launches new Lynlor Oxycodone Capsules in UK

Actavis launches new Lynlor Oxycodone Capsules in UK

29th August 2013

Actavis has announced the introduction of an alternative branded oxycodone immediate release capsule offering called Lynlor Oxycodone Capsules.

Debuting in the UK this month, the therapy is designed for the treatment of severe pain and has been developed at the Actavis manufacturing facility in Barnstaple, where it will also be manufactured.

Available in three strengths of 56 capsules, Lynlor Oxycodone is indicated specifically for cases of severe pain that can only be adequately managed with opioid analgesics.

It is bioequivalent to the branded originator product – with bioequivalence summary data available from Actavis – and will be made available through major wholesalers or directly from the company.

Following the launch of these capsules, the Actavis portfolio now stands at more than 700 branded and generic prescription medicines.

Patients can expect to see the company's product range expanding further still following the completion of its multibillion-dollar takeover of Warner Chilcott, which was announced in May 2013.ADNFCR-8000103-ID-801631044-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.